Recently, Lehrer et al. demonstrated through in silico modeling that insulin can bind to and block Cx43, inhibiting the release and transfer of toxic molecules like glutamate, potentially slowing ALS progression [51]. The gene discussed is GJA1; the disease is amyotrophic lateral sclerosis.